Please login to the form below

Not currently logged in
Email:
Password:

Chinese SFDA recalls contaminated Merck vaccine

Officials from the Chinese State Food and Drug Administration recall more than 100,000 vials of Hib child vaccines manufactured by Merck & Co in the country

Officials from the Chinese State Food and Drug Administration (SFDA) have recalled more than 100,000 vials of Hib child vaccines manufactured by Merck & Co in the country.

The Hib vaccines, Pedvaxhib and Comvax, which Merck & Co recalled in an announcement on 12 December, protect against meningitis, pneumonia and other infections. It is administered as a three-dose regimen to children under age five. The first dose is normally given at the age of two months.

Merck & Co said it could not guarantee the sterility of 1.2 million vials made in a Pennsylvania manufacturing facility. Once China officials received the recall notice, they realised that almost 10 per cent of the recalled supplies were in China.

The vaccine has been administered since October 2007. Up to now, no serious adverse effects have been noted. Parents have been warned to check for redness around the administration site as a precaution.

The 1.2 million vials of potentially contaminated vaccines were delivered to eight municipalities and provinces in China, including Beijing.

20th December 2007

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

WHITE PAPER 05: Improving the effectiveness of clinical trial recruitment materials
With exclusive research conducted by COUCH Health, gain insight into clinical trial recruitment materials best practice....
COVID-19: the race to find a vaccine
How biopharma is working to bring an end to the pandemic...
Guiding star of science leads AstraZeneca to breakthrough in child tumour therapy
Global product lead George Kirk hails the triumph of selumetinib, which has just won FDA approval...

Infographics